Henry F. McFarland - Concepedia

Author

Henry F. McFarland

National Institute of Neurological Disorders and Stroke ORCID

Also Known As

H F McFarland, H McFarland, H. F. MCFARLAND, H. F. McFARLAND, H. F. McFarland, H. McFarland, H.F McFarland, H.F. McFarland, H.F. Mcfarland, HENRY F. MCFARLAND

331

Publications

34.5K

Citations

H-Index

186

Concepts

All Affiliations

National Institute of Neurological Disorders and Stroke National Institutes of Health Georgetown University National Institutes of Health Clinical Center National Institute of Allergy and Infectious Diseases

About

Henry F. McFarland is an author at National Institute of Neurological Disorders and Stroke specializing in medicine, immunology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	128	10.8K
2	Health Sciences	17	18	1.9K
3	Engineering	3	3	799
4	Natural Sciences	2	2	140
5	Public Health	2	2	116

Henry F. McFarland

202

Publications

24.8K

Citations

H-Index

Page 1

	Year	Citations
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis W. I. McDonald, Alistair Compston, Gilles Edan, Annals of Neurology	2001	6.9K
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand Bibiana Bielekova, Bonnie L. Goodwin, Nancy Richert, Nature Medicine Neurodegenerative DiseasesEncephalitogenic PotentialNeurobiology Of DiseaseNeurological DisorderMedicine	2000	819
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases Kevin G. Becker, Richard Simon, Joan E. Bailey‐Wilson, Proceedings of the National Academy of Sciences HlaHistocompatibilityImmunologyPathologyImmunotherapy	1998	593
Regulatory CD56 <sup>bright</sup> natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis Bibiana Bielekova, Marta Catálfamo, Susan Reichert-Scrivner, Proceedings of the National Academy of Sciences	2006	586
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients Paolo A. Muraro, Daniel C. Douek, Katherine Chung, The Journal of Experimental Medicine	2005	495
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA Samantha S. Soldan, Rossana Berti, N. Ben Salem, Nature Medicine Diagnostic VirologyViral PersistenceAutoimmune DiseaseMedicineIgm Response	1997	445
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis David A. Katz, Jeffery K. Taubenberger, Barbara Cannella, Annals of Neurology	1993	387
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis Henry F. McFarland, Joseph A. Frank, Paul S. Albert, Annals of Neurology EngineeringNeurological DisorderMagnetic ResonanceMagnetic Resonance ImagingNeuro-oncology	1992	345
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. Dolores Jaraquemada, M Flerlage, J R Richert, The Journal of Immunology Neurological DisorderImmunodeficienciesT-regulatory CellImmunologyImmune Regulation	1990	342
Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone Bernhard Hemmer, Burkhard Fleckenstein, Marco Vergelli, The Journal of Experimental Medicine	1997	317

Page 1